VCCBH News


Kat Cheung: Interim Leader of Center on Aging

September 27, 2023 by Janet Essman Franz

Katharine Cheung, M.D., Ph.D., assistant professor of medicine, assumed the role of Interim Director of the Center on Aging, effective September 1. A geriatric and palliative nephrologist, Cheung served on the center’s advisory board from 2017-2023. As interim director, Cheung's top priorities include relaunching pilot grants for faculty who are interested in pursuing research focused on gerontology or geriatric issues.

Katharine Cheung, M.D., Ph.D., serves as Interim Director of the Center on Aging.

Katharine L. Cheung, M.D., Ph.D., assistant professor of medicine, assumed the role of Interim Director of the UVM Center on Aging at the Larner College of Medicine, effective September 1, 2023. A geriatric and palliative nephrologist, Cheung served on the Center on Aging faculty advisory board for six years before stepping into the directorship role. She succeeds Michael LaMantia, M.D., M.P.H., associate professor of medicine and division chief for geriatric medicine, who served as the Center on Aging director from 2017-2023.

Cheung came to UVM in 2013 as a postdoctoral associate, following her medical residency at Stanford University School of Medicine. She worked with Larner College of Medicine researchers on a longitudinal study, the Women’s Health Initiative, investigating the association of kidney disease and vasomotor symptoms. She joined the UVM faculty in 2017 and completed her Ph.D. the following year. In 2020 she was recognized as the UVM Health Network Medical Group’s Dean’s Excellence in Research Junior Investigator of the Year.

Cheung is actively engaged in clinical practice, community service, and research focused on the care of older adults with advanced kidney disease and cognitive impairment. Alzheimer’s disease and related dementias affect up to 48 percent of people living with kidney disease, and often go unnoticed. As an investigator in the Vermont Conversation Lab, Cheung uses human coding and artificial intelligence to detect cognitive impairment in palliative care conversations with dialysis patients.

Her longer-term goals include investigating how to best elicit engagement in serious illness conversations for patients with cognitive impairment, as well as determining “whether and how patients with cognitive impairment ought to have these conversations,” Cheung explained.

“Dementia can impact a person’s ability to learn about their diagnosis, weigh risks and benefits of treatment options, and navigate the health care system,” she said. “This is so topical now, in Vermont and across the nation. The numbers of older people and those with dementia are rising, and older adults don’t just have one medical problem, they have multiple medical problems—kidney disease, cancer, liver issues, stroke. They need clinicians to help them balance trade-offs and make decisions.”

In her new role with the Center on Aging, Cheung looks forward to connecting with colleagues across the UVM campus whose work focuses on older people and aging. One of her top priorities is to relaunch the center’s pilot grants initiative for UVM faculty who are interested in pursuing research focused on gerontology or geriatric issues. 

“I imagine there are a lot of people out there whose work in education or research is focused on aging, but they aren’t part of the center yet. As interim director, I have more opportunities to reach out and bring them into the fold, and to have more diverse voices,” she said.

Cheung also anticipates working with community partners to shape policy and inform decisions related to aging issues, health care, and human services. The center collaborates with the UVM Health Network, Vermont Department of Health, Department of Disability, Aging and Independent Living, the Governor’s Commission on Alzheimer’s Disease and Related Dementias, and the Tri-State Learning Collaboration on Aging. 

“I see the Center on Aging as a hub for collaboration. We want to learn about the values and priorities of the community we are serving. We also want to take what we learn and what we teach through our programs to inform policy at the state level.”

One issue of concern is the workforce shortage in Vermont as it pertains to the needs of older people, especially those with dementia, and their caregivers. The center collaborates with the Memory Program at UVM Medical Center on a pilot program that places graduate students in social work internships serving older Vermonters with dementia.

“We have had early success, with participants choosing careers working with older people in Vermont. It’s a great example of how the center collaborates across dementia family care and other colleges in addition to Larner,” said Cheung.  “I’d like to see more ideas like this going forward.”

Center faculty help guide efforts that led UVM to achieve designation as an “Age-Friendly University,” joining a network of higher education institutions committed to promoting positive and healthy aging through teaching, research, and community engagement. As part of these efforts, the center is preparing for a campus-wide survey of aging-related work and activities. “It’s a feather in the cap for the center to have achieved this designation, and we’re looking at this as a way of structuring the priorities of the center,” Cheung said.

Community education initiatives at the Center on Aging also include annual conferences for geriatric health care professionals and a Gerontology Symposium for community members and caregivers. A Grand Friends program matches UVM students with older adult volunteers to foster intergenerational learning, reduce ageism, and boost the psychological, physical, and social well-being of older and younger people.

Cheung mentors medical students, graduate students, and fellows interested in nephrology, geriatrics, communication sciences, and palliative care. She serves the American Society of Nephrology as a Kidney STARS mentor for students, residents, and fellows. She is a past president of the Vermont Kidney Association.

Cheung’s research is supported by the Northern New England Clinical and Translational Research Network and Vermont Center for Cardiovascular and Brain Health, where she serves as a project director investigating vascular mechanisms of cognitive impairment in kidney disease.

Learn more about The Center on Aging at UVM.



Recent Stories and Publications Featuring VCCBH Members


Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted October 23, 2024

In a recent paper published in Nature Communications titled “Endothelial Piezo1 Channel Mediates Mechano-Feedback Control of Brain Blood Flow,” Osama Harraz, Ph.D., Bloomfield Early Career Professor in Cardiovascular Research and assistant professor of pharmacology at the Robert Larner, M.D. College of Medicine, and his team of researchers from American and European institutions reveal that Piezo1, a lesser-understood protein, acts as a “brake” system, helping blood flow return to normal after neural activity.

The association of leptin and incident hypertension in the reasons for geographic and racial differences in stroke (REGARDS) cohort

Posted October 23, 2024

Leptin is an adipokine associated with obesity and with hypertension in animal models. Whether leptin is associated with hypertension independent of obesity is unclear. Relative to White adults, Black adults have higher circulating leptin concentration.

Assessing prenatal and early childhood social and environmental determinants of health in the HEALthy Brain and Child Development Study (HBCD)

Posted October 23, 2024

The HEALthy Brain and Child Development (HBCD) Study, a multi-site prospective longitudinal cohort study, will examine human brain, cognitive, behavioral, social, and emotional development beginning prenatally and planned through early childhood.

Health Watch: UVM researchers unlock secrets of brain blood flow in cognitive health

Posted October 16, 2024

Osama Harraz, Ph.D and his team of researchers at the University of Vermont’s Larner College of Medicine have made a breakthrough that could help in the effort to better understand the causes of dementia and how to stop it.

UVM at the Forefront of Stroke and Brain Health Research

Posted October 14, 2024

REGARDS Study Grant Renewed: UVM’s Continued Contributions to Research on Stroke Disparities by Race and Geography. Investigators at the Larner College of Medicine are receiving a $10.1 million multi-year grant from the National Institutes of Health (NIH) to continue their 23-year program studying stroke and cognitive disorders in the United States.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted October 2, 2024

Investigators at the Larner College of Medicine have received a $10.1 million multi-year grant from the National Institutes of Health to continue their work on the REGARDS project. The purpose of the project is to understand why those in some U.S. regions develop more strokes and Alzheimer’s Disease and Related Dementia than others, and why Black people develop more strokes than white people.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted August 21, 2024

Mark Nelson, Ph.D., chair and University Distinguished Professor of pharmacology, gave the Björn Folkow Lecture at the 15th Mechanisms of Vasodilation/Endothelium-Dependent Hyperpolarization (MOVD/EDH) 2024 conference July 2–5 at Magdalen College in Oxford, United Kingdom.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted July 31, 2024

A collaborative research team co-led by investigators David Jangraw, Ph.D., M.S., and Denise Peters, Ph.D., D.P.T., PT, has been awarded the 2024 Armin Grams Memorial Research Award by the Center on Aging. 

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted July 10, 2024

Two Larner-affiliated researchers won their respective poster competitions at the Vermont Center for Cardiovascular and Brain Health symposium held June 6–7 at the University of Vermont’s Davis Center.

Movement of the endoplasmic reticulum is driven by multiple classes of vesicles marked by Rab-GTPases

Posted May 15, 2024

John Salogiannis, Ph.D., assistant professor of molecular physiology and biophysics, and members of his lab team—Allison (Morrissey) Langley, lab technician and Ph.D. candidate in cellular, molecular, and biomedical sciences; Sarah Abeling-Wang, lab research technician; and Erinn Wagner, UVM undergraduate biology major—have their first preprint*: “Movement of the endoplasmic reticulum is driven by multiple classes of vesicles marked by Rab-GTPases.” The team’s research is supported by an NIH Maximizing Investigators’ Research Award (MIRA or R35) for early-stage investigators.

The University of Vermont Center on Aging Newsletter

Posted May 2024

Katharine Cheung, M.D., Ph.D., M.Sc., interim director of the UVM Center on Aging, associate director for research, and assistant professor of medicine, and her mentee, medical student Susanna Schuler ’26, presented their research findings at the American Academy of Hospice and Palliative Medicine State of the Science meeting on March 23 in Phoenix, Arizona.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted March 6, 2024

A study by a nationwide collaborative group, including Larner scientists Mary Cushman, M.D., M.Sc., University of Vermont Distinguished Professor and co-director of the Vermont Center for Cardiovascular and Brain Health, Russell Tracy, Ph.D., University of Vermont Distinguished Professor and director of UVM’s Laboratory for Clinical Biochemistry Research, Margaret Doyle Ph.D., associate professor of Pathology and Laboratory Medicine and co-director of the Laboratory of Clinical Biochemistry, and Rebekah Boyle, M.S., was recently published in Nature Communications.

 

UVM Scientist Wins Chan Zuckerberg Initiative Grant to Tackle Neurodegenerative Diseases

Larner Scientist Seeks to Advance Neurodegeneration Research

February 22, 2024

Larner College of Medicine scientist Osama Harraz, Ph.D., M.Sc., and his colleague from the University of Maryland (UMD), Thomas Longden, Ph.D., are recipients of a prestigious Collaborative Pairs Pilot Project Award from the Chan Zuckerberg Initiative’s (CZI) Neurodegeneration Challenge Network (NCDN).